TrianglePUBLICATIONS · 12791647
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2003 Oct 1
- First author
- Kantarjian H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kantarjian H
- type
- Author
- name
- Gandhi V
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Verstovsek S
- type
- Author
- name
- Du M
- type
- Author
- name
- Garcia-Manero G
- type
- Author
- name
- Giles F
- type
- Author
- name
- Faderl S
- type
- Author
- name
- O'Brien S
- type
- Author
- name
- Jeha S
- type
- Author
- name
- Davis J
- type
- Author
- name
- Shaked Z
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kantarjian H
- type
- Author
- name
- Gandhi V
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Verstovsek S
- type
- Author
- name
- Du M
- type
- Author
- name
- Garcia-Manero G
- type
- Author
- name
- Giles F
- type
- Author
- name
- Faderl S
- type
- Author
- name
- O'Brien S
- type
- Author
- name
- Jeha S
- type
- Author
- name
- Davis J
- type
- Author
- name
- Shaked Z
- type
- Author
- bibliography ids
- nci-bib-aaf643e9ecfa693f93db5ad1
- book metadata
- content sha256
- 6f503593129dcd5ee8e6a7de1269608b9f39bce4bd9770207c82df563657aa89
- document type
- citation
- dois
- 10.1182/blood-2003-03-0925
- electronic publication date
- display
- 2003 Jun 5
- precision
- day
- year
- 2003
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12791647
- immutable id
- pubmed:12791647@6f503593129dcd5ee8e6a7de1269608b9f39bce4bd9770207c82df563657aa89
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 7
- name
- Blood
- nlm unique id
- 7603509
- pages
- 2379-86
- volume
- 102
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 12791647
- provenance
- batch id
- 2d0158fe73b50bb1a4bf
- provider
- NCBI PubMed ESummary
- record sha256
- 301c6a23303968a2fb3cb700bdef4c57cc559060dd9ec78f34166a49165c4894
- response sha256
- d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
- retrieved at
- 2026-09-09T23:45:50.935339+00:00
- publication date
- display
- 2003 Oct 1
- precision
- day
- year
- 2003
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Research Support, U.S. Gov't, Non-P.H.S.
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.
Preserved source evidence · Not medical advice